Patent · US Active

Use of cyclic depsipeptides to inhibit kallikrein 7

US8415305B2 · kind B2 · utility

11Cited by

1References

8Claims

0Family size

Assignee

Novartis AG · CH

Inventors

Philipp Krastel · Weil am Rhein, DE
Brigitta-Maria Liechty · Basel, CH
Esther Schmitt · Bad Kötzting, DE
Erwin Schreiner · Wien, AT

Key dates

Filing date	Aug 14, 2008
Grant date	Apr 9, 2013
Priority date	—
Expiry date	Aug 14, 2028

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61K38/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present application relates to cyclic depsipeptides of Formula I: or derivatives thereof, wherein X, A1, A2, A3, A4, A5, A6 and A7 are defined herein. The cyclic depsipeptides of Formula I are inhibitors of kallikrein 7 and thus can be employed for the treatment of kallikrein-7 dependent diseases.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.